International Society on Thrombosis and Haemostasis/LinkedIn
Aug 29, 2026, 17:05
What If Factor XI inhibition Could Reshape the Future of Anticoagulation – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
”Could Factor XI inhibition reshape the future of anticoagulation?
Explore the science behind FXI and FXIa inhibitors, an emerging generation of anticoagulant therapies with the potential to influence future clinical practice.
In this recorded session, Jeff Weitz breaks down:
- The major classes of FXI/FXIa inhibitors
- Where they act within the coagulation cascade
- Leading investigational compounds in clinical trials
- Recent clinical data and key study findings
Animated charts and concise summaries make it easy to follow the evolving evidence and understand where the field may be headed next.
Watch the session on demand.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 14:58Aishwarya Dash: Simplifying Bone Marrow Mesenchymal Stromal Cell Isolation
-
Oct 18, 2026, 14:54Caitlin Raymond: Could the Apheresis Circuit Itself Modulate Immunity?
-
Oct 18, 2026, 13:0810 Posts Not to Miss This Week
-
Oct 18, 2026, 12:58Pierpaolo Di Micco: DOACs vs Vitamin K Antagonists in Long-Term Anticoagulation
-
Oct 18, 2026, 12:51Arianne Missimer: Understanding Ferritin Levels Beyond the Normal Range
-
Oct 18, 2026, 12:37Roberto C. Iglesias: Colon Cancer Prevention Beyond Supplements and Vitamins
-
Oct 18, 2026, 12:27Rafael Alejandro Camero Del Vecchio: Paroxysmal Nocturnal Hemoglobinuria Advancing Complement Inhibition with Ravulizumab
-
Oct 18, 2026, 12:26Abdul Mannan: When INR Misleads – Rethinking Bleeding Risk in Cirrhosis
-
Oct 18, 2026, 12:14Stéphane Laurent: The People and Technology Behind Safe Blood Transfusion